Literature DB >> 10586458

A comparison of pain, functional limitations, and work status indices as outcome measures in back pain research.

C E Dionne1, M Von Korff, T D Koepsell, R A Deyo, W E Barlow, H Checkoway.   

Abstract

STUDY
DESIGN: We conducted a prospective study with a 2-year follow-up.
OBJECTIVE: To compare pain, functional limitations, and work status indices as measures of outcome among back pain patients. SUMMARY OF BACKGROUND DATA: Work status, pain, and functional limitations indices are often considered as interchangeable outcome measures in back pain research. This perspective has been criticized by several authors, who argue that each of these outcome measures reflects a different construct that may vary independently of the others.
METHODS: The study was conducted on 720 patients, who sought care for back pain in primary care settings of a large health maintenance organization in 1989-90, and were interviewed one month and two years later. X2 analyses and receiver operating characteristic curves were used to compare the accuracy of a pain rating and a modified 16-item Roland-Morris score in classifying patients on work status and on the change in work status over time.
RESULTS: Moderate agreement between the pain and functional limitations measures and work status was observed. Pain and functional limitations change scores agreed moderately with improvement in work status, but were poorly associated with decline in work status.
CONCLUSIONS: Although the pain, functional limitations, and work status indices examined in this study are related, they are not equivalent and should not be regarded as interchangeable. These results argue for a clearer distinction of outcome measures in back pain research.

Entities:  

Mesh:

Year:  1999        PMID: 10586458     DOI: 10.1097/00007632-199911150-00009

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  20 in total

1.  Is disability underreported following work injury?

Authors:  Bradley Evanoff; Sakena Abedin; Deborah Grayson; Ann Marie Dale; Laurie Wolf; Paula Bohr
Journal:  J Occup Rehabil       Date:  2002-09

Review 2.  Condition-specific outcome measures for low back pain. Part I: validation.

Authors:  U Müller; M S Duetz; C Roeder; C G Greenough
Journal:  Eur Spine J       Date:  2004-03-17       Impact factor: 3.134

3.  [Fear avoidance beliefs in patients with back pain. Psychometric properties of the German version of the FABQ].

Authors:  M Pfingsten
Journal:  Schmerz       Date:  2004-02       Impact factor: 1.107

4.  Comparing current definitions of return to work: a measurement approach.

Authors:  I A Steenstra; H Lee; E M M de Vroome; J W Busse; S J Hogg-Johnson
Journal:  J Occup Rehabil       Date:  2012-09

5.  Differences among outcome measures in occupational low back pain.

Authors:  Sue A Ferguson; William S Marras; Deborah L Burr
Journal:  J Occup Rehabil       Date:  2005-09

Review 6.  Back related outcome assessment instruments.

Authors:  Urs Müller; Christoph Röder; Charles G Greenough
Journal:  Eur Spine J       Date:  2005-11-16       Impact factor: 3.134

7.  Health-related quality of life assessment by the EuroQol-5D can provide cost-utility data in the field of low-back surgery.

Authors:  Tore K Solberg; Jan-Abel Olsen; Tor Ingebrigtsen; Dag Hofoss; Oystein P Nygaard
Journal:  Eur Spine J       Date:  2005-04-21       Impact factor: 3.134

Review 8.  Work-related outcome assessment instruments.

Authors:  Achim Elfering
Journal:  Eur Spine J       Date:  2005-11-23       Impact factor: 3.134

Review 9.  Treatment of impingement syndrome: a systematic review of the effects on functional limitations and return to work.

Authors:  Elske Faber; Judith I Kuiper; Alex Burdorf; Harald S Miedema; Jan A N Verhaar
Journal:  J Occup Rehabil       Date:  2006-03

10.  Pain characteristic differences between subacute and chronic back pain.

Authors:  Mona Lisa Chanda; Matthew D Alvin; Thomas J Schnitzer; A Vania Apkarian
Journal:  J Pain       Date:  2011-04-15       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.